Metastatic risk and resistance to BRAF inhibitors in melanoma defined by selective allelic loss of ATG5

References

• TCGA. Genomic Classification of Cutaneous Melanoma. Cell 2015; 161:1681-96; PMID:26091043; http://dx.doi.org/10.1016/j.cell.2015.05.044
   PubMed Web of Science ®Google Scholar
• Tsao H, Chin L, Garraway LA, Fisher DE. Melanoma: from mutations to medicine. Genes Dev 2012; 26:1131-55; PMID:22661227; http://dx.doi.org/10.1101/gad.191999.112
   PubMed Web of Science ®Google Scholar
• Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, Carter SL, Stewart C, Mermel CH, Roberts SA, et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 2013; 499:214-8; PMID:23770567; http://dx.doi.org/10.1038/nature12213
   PubMed Web of Science ®Google Scholar
• Hodis E, Watson IR, Kryukov GV, Arold S, Imielinski M, Thereurillat J-P, Nickerson E, Auclair D, Li L, Place C, et al. A Landscape of Driver Mutations in Melanoma. Cell 2012; 150:251-63; PMID:22817889; http://dx.doi.org/10.1016/j.cell.2012.06.024
   PubMed Web of Science ®Google Scholar
• Huang FW, Hodis E, Xu MJ, Kryukov GV, Chin L, Garraway LA. Highly recurrent TERT promoter mutations in human melanoma. Science 2013; 339:957-9; PMID:23348506; http://dx.doi.org/10.1126/science.1229259
   PubMed Web of Science ®Google Scholar
• Krauthammer M, Kong Y, Ha BH, Evans P, Bacchiocchi A, McCusker JP, Cheng E, Davis MJ, Goh G, Choi M, et al. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet 2012; 44:1006-14; PMID:22842228; http://dx.doi.org/10.1038/ng.2359
   PubMed Web of Science ®Google Scholar
• Whiteman DC, Pavan WJ, Bastian BC. The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin. Pigment Cell Melanoma Res 2011; 24:879-97; PMID:21707960; http://dx.doi.org/10.1111/j.1755-148X.2011.00880.x
   PubMed Web of Science ®Google Scholar
• Villanueva J, Herlyn M. Melanoma and the tumor microenvironment. Curr Oncol Rep 2008; 10:439-46; PMID:18706274; http://dx.doi.org/10.1007/s11912-008-0067-y
   PubMed Web of Science ®Google Scholar
• Roesch A, Fukunaga-Kalabis M, Schmidt EC, Zabierowski SE, Brafford PA, Vultur A, Basu D, Gimotty P, Vogt T, Herlyn M. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 2010; 141:583-94; PMID:20478252; http://dx.doi.org/10.1016/j.cell.2010.04.020
   PubMed Web of Science ®Google Scholar
• Aplin A, Bosenberg M, Soengas M, Kos L, Arnheiter H, Kelsh R. Unmet needs in melanoma research. Pigment Cell Melanoma Res 2014; 27:1003; PMID:25346049; http://dx.doi.org/10.1111/pcmr.12321
   PubMed Web of Science ®Google Scholar
• Akavia UD, Litvin O, Kim J, Sanchez-Garcia F, Kotliar D, Causton HC, Pochanard P, Mozes E, Garraway LA, Pe'er D. An integrated approach to uncover drivers of cancer. Cell 2010; 143:1005-17; PMID:21129771; http://dx.doi.org/10.1016/j.cell.2010.11.013
   PubMed Web of Science ®Google Scholar
• Garraway LA, Sellers WR. Lineage dependency and lineage-survival oncogenes in human cancer. Nat Rev Cancer 2006; 6:593-602; PMID:16862190; http://dx.doi.org/10.1038/nrc1947
   PubMed Web of Science ®Google Scholar
• Pinner S, Jordan P, Sharrock K, Bazley L, Collinson L, Marais R, Bonvin E, Goding C, Sahai E. Intravital imaging reveals transient changes in pigment production and Brn2 expression during metastatic melanoma dissemination. Cancer Res 2009; 69:7969-77; PMID:19826052; http://dx.doi.org/10.1158/0008-5472.CAN-09-0781
   PubMed Web of Science ®Google Scholar
• Vance KW, Goding CR. The transcription network regulating melanocyte development and melanoma. Pigment Cell Res 2004; 17:318-25; PMID:15250933; http://dx.doi.org/10.1111/j.1600-0749.2004.00164.x
   PubMedGoogle Scholar
• Caramel J, Papadogeorgakis E, Hill L, Browne GJ, Richard G, Wierinckx A, Saldanha G, Osborne J, Hutchinson P, Tse G, et al. A Switch in the Expression of Embryonic EMT-Inducers Drives the Development of Malignant Melanoma. Cancer Cell 2013; 24:466-80; PMID:24075834; http://dx.doi.org/10.1016/j.ccr.2013.08.018
   PubMed Web of Science ®Google Scholar
• Johannessen CM, Johnson LA, Piccioni F, Townes A, Frederick DT, Donahue MK, Narayan R, Flaherty KT, Wargo JA, Root DE, et al. A melanocyte lineage program confers resistance to MAP kinase pathway inhibition. Nature 2013; 504:138-42; PMID:24185007; http://dx.doi.org/10.1038/nature12688
   PubMed Web of Science ®Google Scholar
• Van Allen EM, Wagle N, Sucker A, Treacy DJ, Johannessen CM, Goetz EM, Place CS, Taylor-Weiner A, Whittaker S, Kryukov GV, et al. The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma. Cancer Discov 2014; 4:94-109; PMID:24265153; http://dx.doi.org/10.1158/2159-8290.CD-13-0617
   PubMed Web of Science ®Google Scholar
• Muller J, Krijgsman O, Tsoi J, Robert L, Hugo W, Song C, Kong X, Possik PA, Cornelissen-Steijger PD, Foppen MH, et al. Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma. Nat Commun 2014; 5:5712; PMID:25502142; http://dx.doi.org/10.1038/ncomms6712
   PubMed Web of Science ®Google Scholar
• Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S, Beroukhim R, Milner DA, Granter SR, Du J, et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 2005; 436:117-22; PMID:16001072; http://dx.doi.org/10.1038/nature03664
   PubMed Web of Science ®Google Scholar
• Thurber AE, Douglas G, Sturm EC, Zabierowski SE, Smit DJ, Ramakrishnan SN, Hacker E, Leonard JH, Herlyn M, Sturm RA. Inverse expression states of the BRN2 and MITF transcription factors in melanoma spheres and tumour xenografts regulate the NOTCH pathway. Oncogene 2011; 30:3036-48; PMID:21358674; http://dx.doi.org/10.1038/onc.2011.33
   PubMed Web of Science ®Google Scholar
• Bell RE, Levy C. The three M's: melanoma, microphthalmia-associated transcription factor and microRNA. Pigment Cell Melanoma Res 2011; 24:1088-106; PMID:22004179; http://dx.doi.org/10.1111/j.1755-148X.2011.00931.x
   PubMed Web of Science ®Google Scholar
• Javelaud D, Alexaki VI, Pierrat MJ, Hoek KS, Dennler S, Van Kempen L, Bertolotto C, Ballotti R, Saule S, Delmas V, et al. GLI2 and M-MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells. Pigment Cell Melanoma Res 2011; 24:932-43; PMID:21801332; http://dx.doi.org/10.1111/j.1755-148X.2011.00893.x
   PubMed Web of Science ®Google Scholar
• Koludrovic D, Davidson I. MITF, the Janus transcription factor of melanoma. Future Oncol 2013; 9:235-44; PMID:23414473; http://dx.doi.org/10.2217/fon.12.177
   PubMed Web of Science ®Google Scholar
• Alonso-Curbelo D, Riveiro-Falkenbach E, Perez-Guijarro E, Cifdaloz M, Karras P, Osterloh L, Megias D, Canon E, Calvo TG, Olmeda D, et al. RAB7 controls melanoma progression by exploiting a lineage-specific wiring of the endolysosomal pathway. Cancer Cell 2014; 26:61-76; PMID:24981740; http://dx.doi.org/10.1016/j.ccr.2014.04.030
   PubMed Web of Science ®Google Scholar
• Alonso-Curbelo D, Osterloh L, Canon E, Calvo TG, Martinez-Herranz R, Karras P, Martinez S, Riveiro-Falkenbach E, Romero PO, Rodriguez-Peralto JL, et al. RAB7 counteracts PI3K-driven macropinocytosis activated at early stages of melanoma development. Oncotarget 2015; 6:11848-62; PMID:26008978; http://dx.doi.org/10.18632/oncotarget.4055
   PubMed Web of Science ®Google Scholar
• Alonso-Curbelo D, Soengas MS. Hyperactivated endolysosomal trafficking in melanoma. Oncotarget 2015; 6:2583-4; PMID:25682879; http://dx.doi.org/10.18632/oncotarget.3141
   PubMed Web of Science ®Google Scholar
• Ploper D, Taelman VF, Robert L, Perez BS, Titz B, Chen HW, Graeber TG, von Euw E, Ribas A, De Robertis EM. MITF drives endolysosomal biogenesis and potentiates Wnt signaling in melanoma cells. Proc Natl Acad Sci U S A 2015; 112:E420-9; PMID:25605940; http://dx.doi.org/10.1073/pnas.1424576112
   PubMed Web of Science ®Google Scholar
• Checinska A, Soengas MS. The gluttonous side of malignant melanoma: basic and clinical implications of macroautophagy. Pigment Cell Melanoma Res 2012; 24:1116-32; http://dx.doi.org/10.1111/j.1755-148X.2011.00927.x
   Web of Science ®Google Scholar
• Maes H, Agostinis P. Autophagy and mitophagy interplay in melanoma progression. Mitochondrion 2014; 19Pt A:58-68; PMID:25042464; http://dx.doi.org/10.1016/j.mito.2014.07.003
   PubMed Web of Science ®Google Scholar
• Maddodi N, Huang W, Havighurst T, Kim K, Longley BJ, Setaluri V. Induction of autophagy and inhibition of melanoma growth in vitro and in vivo by hyperactivation of oncogenic BRAF. J Invest Dermatol 2010; 130:1657-67; PMID:20182446; http://dx.doi.org/10.1038/jid.2010.26
   PubMed Web of Science ®Google Scholar
• Amaravadi RK, Yu D, Lum JJ, Bui T, Christophorou MA, Evan GI, Thomas-Tikhonenko A, Thompson CB. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest 2007; 117:326-36; PMID:17235397; http://dx.doi.org/10.1172/JCI28833
   PubMed Web of Science ®Google Scholar
• Goodall ML, Wang T, Martin KR, Kortus MG, Kauffman AL, Trent JM, Gately S, MacKeigan JP. Development of potent autophagy inhibitors that sensitize oncogenic BRAF V600E mutant melanoma tumor cells to vemurafenib. Autophagy 2014; 10:1120-36; PMID:24879157; http://dx.doi.org/10.4161/auto.28594
   PubMed Web of Science ®Google Scholar
• Ma Y, Hendershot LM. The stressful road to antibody secretion. Nat Immunol 2003; 4:310-1; PMID:12660729; http://dx.doi.org/10.1038/ni0403-310
   PubMed Web of Science ®Google Scholar
• Tormo D, Checinska A, Alonso-Curbelo D, Perez-Guijarro E, Canon E, Riveiro-Falkenbach E, Calvo TG, Larribere L, Megias D, Mulero F, et al. Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cells. Cancer Cell 2009; 16:103-14; PMID:19647221; http://dx.doi.org/10.1016/j.ccr.2009.07.004
   PubMed Web of Science ®Google Scholar
• Lebovitz CB, Robertson AG, Goya R, Jones SJ, Morin RD, Marra MA, Gorski SM. Cross-cancer profiling of molecular alterations within the human autophagy interaction network. Autophagy 2015; 11:1668-87; PMID:26208877; http://dx.doi.org/10.1080/15548627.2015.1067362
   PubMed Web of Science ®Google Scholar
• Lazova R, Klump V, Pawelek J. Autophagy in cutaneous malignant melanoma. J Cutan Pathol 2010; 37:256-68. PMID: 19615007; http://dx.doi.org/10.1111/j.1600-0560.2009.01359.x
   Google Scholar
• Miracco C, Cevenini G, Franchi A, Luzi P, Cosci E, Mourmouras V, Monciatti I, Mannucci S, Biagioli M, Toscano M, et al. Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions. Hum Pathol 2010; 41:503-12; PMID:20004946; http://dx.doi.org/10.1016/j.humpath.2009.09.004
   PubMed Web of Science ®Google Scholar
• Sivridis E, Koukourakis MI, Mendrinos SE, Karpouzis A, Fiska A, Kouskoukis C, Giatromanolaki A. Beclin-1 and LC3A expression in cutaneous malignant melanomas: a biphasic survival pattern for beclin-1. Melanoma Res 2011; 21:188-95; PMID:21537144; http://dx.doi.org/10.1097/CMR.0b013e328346612c
   PubMed Web of Science ®Google Scholar
• Xie X, Koh JY, Price S, White E, Mehnert JM. Atg7 Overcomes Senescence and Promotes Growth of BrafV600E-Driven Melanoma. Cancer Discov 2015; 5:410-23; PMID:25673642; http://dx.doi.org/10.1158/2159-8290.CD-14-1473
   PubMed Web of Science ®Google Scholar
• Liu H, He Z, von Rutte T, Yousefi S, Hunger RE, Simon HU. Down-regulation of autophagy-related protein 5 (ATG5) contributes to the pathogenesis of early-stage cutaneous melanoma. Sci Transl Med 2013; 5:202ra123; PMID:24027027; http://dx.doi.org/10.1126/scitranslmed.3005864
   PubMed Web of Science ®Google Scholar
• Maes H, Kuchnio A, Peric A, Moens S, Nys K, De Bock K, et al. Tumor vessel normalization by chloroquine independent of autophagy. Cancer Cell 2014; 26:190-206. PMID:25117709; http://dx.doi.org/10.1016/j.ccr.2014.06.025.
   Google Scholar
• Yang Z, Klionsky DJ. Eaten alive: a history of macroautophagy. Nat Cell Biol 2010; 12:814-22; PMID:20811353; http://dx.doi.org/10.1038/ncb0910-814
   PubMed Web of Science ®Google Scholar
• Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S, Wilson CJ, Lehar J, Kryukov GV, Sonkin D, et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 2012; 483:603-7; PMID:22460905; http://dx.doi.org/10.1038/nature11003
   PubMed Web of Science ®Google Scholar
• Marzese DM, Scolyer RA, Huynh JL, Huang SK, Hirose H, Chong KK, Kiyohara E, Wang J, Kawas NP, Donovan NC, et al. Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis. Hum Mol Genet 2014; 23:226-38; PMID:24014427; http://dx.doi.org/10.1093/hmg/ddt420
   PubMed Web of Science ®Google Scholar
• Soengas MS, Capodieci P, Polsky D, Mora J, Esteller M, Opitz-Araya X, McCombie R, Herman JG, Gerald WL, Lazebnik YA, et al. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature 2001; 409:207-11; PMID:11196646; http://dx.doi.org/10.1038/35051606
   PubMed Web of Science ®Google Scholar
• Behrends C, Sowa ME, Gygi SP, Harper JW. Network organization of the human autophagy system. Nature 2010; 466:68-76; PMID:20562859; http://dx.doi.org/10.1038/nature09204
   PubMed Web of Science ®Google Scholar
• Trent JM, Rosenfeld SB, Meyskens FL. Chromosome 6q involvement in human malignant melanoma. Cancer Genet Cytogenet 1983; 9:177-80; PMID:6850557; http://dx.doi.org/10.1016/0165-4608(83)90039-0
   PubMedGoogle Scholar
• Hoshimoto S, Kuo CT, Chong KK, Takeshima TL, Takei Y, Li MW, Huang SK, Sim MS, Morton DL, Hoon DS. AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome. J Invest Dermatol 2012; 132:1689-97; PMID:22402438; http://dx.doi.org/10.1038/jid.2012.36
   PubMed Web of Science ®Google Scholar
• Kim M, Jang HR, Haam K, Kang TW, Kim JH, Kim SY, Noh SM, Song KS, Cho JS, Jeong HY, et al. Frequent silencing of popeye domain-containing genes, BVES and POPDC3, is associated with promoter hypermethylation in gastric cancer. Carcinogenesis 2010; 31:1685-93; PMID:20627872; http://dx.doi.org/10.1093/carcin/bgq144
   PubMed Web of Science ®Google Scholar
• Karube K, Nakagawa M, Tsuzuki S, Takeuchi I, Honma K, Nakashima Y, Shimizu N, Ko YH, Morishima Y, Ohshima K, et al. Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses. Blood 2011; 118:3195-204; PMID:21690554; http://dx.doi.org/10.1182/blood-2011-04-346890
   PubMed Web of Science ®Google Scholar
• Santos GC, Zielenska M, Prasad M, Squire JA. Chromosome 6p amplification and cancer progression. J Clin Pathol 2007; 60:1-7; PMID:16790693; http://dx.doi.org/10.1136/jcp.2005.034389
   PubMed Web of Science ®Google Scholar
• Kuma A, Hatano M, Matsui M, Yamamoto A, Nakaya H, Yoshimori T, Ohsumi Y, Tokuhisa T, Mizushima N. The role of autophagy during the early neonatal starvation period. Nature 2004; 432:1032-6; PMID:15525940; http://dx.doi.org/10.1038/nature03029
   PubMed Web of Science ®Google Scholar
• Yajima I, Belloir E, Bourgeois Y, Kumasaka M, Delmas V, Larue L. Spatiotemporal gene control by the Cre-ERT2 system in melanocytes. Genesis 2006; 44:34-43; PMID:16419042; http://dx.doi.org/10.1002/gene.20182
   PubMed Web of Science ®Google Scholar
• Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, Suzuki-Migishima R, Yokoyama M, Mishima K, Saito I, Okano H, et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 2006; 441:885-9; PMID:16625204; http://dx.doi.org/10.1038/nature04724
   PubMed Web of Science ®Google Scholar
• Dankort D, Curley DP, Cartlidge RA, Nelson B, Karnezis AN, Damsky WE, Jr., You MJ, DePinho RA, McMahon M, Bosenberg M. Braf(V600E) cooperates with Pten loss to induce metastatic melanoma. Nat Genet 2009; 41:544-52; PMID:19282848; http://dx.doi.org/10.1038/ng.356
   PubMed Web of Science ®Google Scholar
• Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, van der Horst CM, Majoor DM, Shay JW, Mooi WJ, Peeper DS. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 2005; 436:720-4; PMID:16079850; http://dx.doi.org/10.1038/nature03890
   PubMed Web of Science ®Google Scholar
• Denoyelle C, Abou-Rjaily G, Bezrookove V, Verhaegen M, Johnson TM, Fullen DR, Pointer JN, Gruber SB, Su LD, Nikiforov MA, et al. Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway. Nat Cell Biol 2006; 8:1053-63; PMID:16964246; http://dx.doi.org/10.1038/ncb1471
   PubMed Web of Science ®Google Scholar
• Haass NK, Smalley KS, Li L, Herlyn M. Adhesion, migration and communication in melanocytes and melanoma. Pigment Cell Res 2005; 18:150-9; PMID:15892711; http://dx.doi.org/10.1111/j.1600-0749.2005.00235.x
   PubMedGoogle Scholar
• Rao S, Tortola L, Perlot T, Wirnsberger G, Novatchkova M, Nitsch R, Sykacek P, Frank L, Schramek D, Komnenovic V, et al. A dual role for autophagy in a murine model of lung cancer. Nat Commun 2014; 5:3056; PMID:24445999; http://dx.doi.org/10.1038/ncomms4056
   PubMed Web of Science ®Google Scholar
• Thorburn A, Morgan MJ. Targeting Autophagy in BRAF-Mutant Tumors. Cancer Discov 2015; 5:353-4; PMID:25847956; http://dx.doi.org/10.1158/2159-8290.CD-15-0222
   PubMed Web of Science ®Google Scholar
• Martin S, Dudek-Peric AM, Maes H, Garg AD, Gabrysiak M, Demirsoy S, Swinnen JV, Agostinis P. Concurrent MEK and autophagy inhibition is required to restore cell death associated danger-signalling in Vemurafenib-resistant melanoma cells. Biochem Pharmacol 2015; 93:290-304; PMID:25529535; http://dx.doi.org/10.1016/j.bcp.2014.12.003
   PubMed Web of Science ®Google Scholar
• Corazzari M, Rapino F, Ciccosanti F, Giglio P, Antonioli M, Conti B, Fimia GM, Lovat PE, Piacentini M. Oncogenic BRAF induces chronic ER stress condition resulting in increased basal autophagy and apoptotic resistance of cutaneous melanoma. Cell Death Differ 2015; 22:946-58; PMID:25361077; http://dx.doi.org/10.1038/cdd.2014.183
   PubMed Web of Science ®Google Scholar
• Flaherty KT. Targeting metastatic melanoma. Annu Rev Med 2012; 63:171-83; PMID:22034865; http://dx.doi.org/10.1146/annurev-med-050410-105655
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100:57-70; PMID:10647931; http://dx.doi.org/10.1016/S0092-8674(00)81683-9
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646-74; PMID:21376230; http://dx.doi.org/10.1016/j.cell.2011.02.013
   PubMed Web of Science ®Google Scholar
• Zhang T, Zhou Q, Ogmundsdottir MH, Moller K, Siddaway R, Larue L, Hsing M, Kong SW, Goding CR, Palsson A, et al. Mitf is a master regulator of the v-ATPase, forming a control module for cellular homeostasis with v-ATPase and TORC1. J Cell Sci 2015; 128:2938-50; PMID:26092939; http://dx.doi.org/10.1242/jcs.173807
   PubMed Web of Science ®Google Scholar
• Luke JJ, Hodi FS. Ipilimumab, vemurafenib, dabrafenib, and trametinib: synergistic competitors in the clinical management of BRAF mutant malignant melanoma. Oncologist 2013; 18:717-25. PMID: 23709751; http://dx.doi.org/10.1634/theoncologist.2012-0391.
   Google Scholar
• Xie Z, Klionsky DJ. Autophagosome formation: core machinery and adaptations. Nat Cell Biol 2007; 9:1102-9; PMID:17909521; http://dx.doi.org/10.1038/ncb1007-1102
   PubMed Web of Science ®Google Scholar
• Feng Y, Yao Z, Klionsky DJ. How to control self-digestion: transcriptional, post-transcriptional, and post-translational regulation of autophagy. Trends Cell Biol 2015; 25:354-63. PMID: 25759175; http://dx.doi.org/10.1016/j.tcb.2015.02.002
   Google Scholar
• Wang L, Wang Y, Lu Y, Zhang Q, Qu X. Heterozygous deletion of ATG5 in Apc(Min/+) mice promotes intestinal adenoma growth and enhances the antitumor efficacy of interferon-gamma. Cancer Biol Ther 2015; 16:383-91; PMID:25695667; http://dx.doi.org/10.1080/15384047.2014.1002331
   PubMed Web of Science ®Google Scholar
• Bis S, Tsao H. Melanoma genetics: the other side. Clin Dermatol 2013; 31:148-55; PMID:23438378; http://dx.doi.org/10.1016/j.clindermatol.2012.08.003
   PubMed Web of Science ®Google Scholar
• Bastian BC. The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia. Annu Rev Pathol 2014; 9:239-71; PMID:24460190; http://dx.doi.org/10.1146/annurev-pathol-012513-104658
   PubMed Web of Science ®Google Scholar
• Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014; 64:9-29; PMID:24399786; http://dx.doi.org/10.3322/caac.21208
   PubMed Web of Science ®Google Scholar
• Harbour JW. The genetics of uveal melanoma: an emerging framework for targeted therapy. Pigment Cell Melanoma Res 2012; 25:171-81; PMID:22268848; http://dx.doi.org/10.1111/j.1755-148X.2012.00979.x
   PubMed Web of Science ®Google Scholar
• Kraya AA, Piao S, Xu X, Zhang G, Herlyn M, Gimotty P, Levine B, Amaravadi RK, Speicher DW. Identification of secreted proteins that reflect autophagy dynamics within tumor cells. Autophagy 2015; 11:60-74; PMID:25484078; http://dx.doi.org/10.4161/15548627.2014.984273
   PubMed Web of Science ®Google Scholar
• Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2012; 2:401-4; PMID:22588877; http://dx.doi.org/10.1158/2159-8290.CD-12-0095
   PubMed Web of Science ®Google Scholar
• Marino S, Krimpenfort P, Leung C, van der Korput HA, Trapman J, Camenisch I, Berns A, Brandner S. PTEN is essential for cell migration but not for fate determination and tumourigenesis in the cerebellum. Development 2002; 129:3513-22; PMID:12091320
   PubMed Web of Science ®Google Scholar